Scailyte and Lexogen create a joint biomarker discovery workflow for precision medicine companies
Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solutions, announce a strategic partnership. The companies will create a joint biomarker discovery workflow, leveraging Lexogen’s new


